Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.
Press releases published on July 28, 2025
Global Benlysta Market Forecast To Reach $3.6 Billion By 2029 With 11.2% Annual Growth
EIN Presswire
·
July 28, 2025
The Business Research Company's Benlysta Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, July 28, 2025 /EINPresswire.com/ -- Save 30% on all global market reports with code ONLINE30 …
The Assistive Technologies for Visually Impaired Market Poised for Growth, Expected to Reach $12.31 Billion by 2029
EIN Presswire
·
July 28, 2025
The Business Research Company’s Assistive Technologies for Visually Impaired Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, July 28, 2025 /EINPresswire.com/ -- What Does The Current Growth …
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
GlobeNewswire
·
July 28, 2025
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits Broad label includes adults and adolescents with C3G or primary IC-MPGN, and post-transplant …
North Park Nursing Student Receives Prestigious Schweitzer Fellowship
GlobeNewswire
·
July 28, 2025
Chicago, July 28, 2025 (GLOBE NEWSWIRE) -- Victoria Roehl, a student in the Master of Nursing Leadership program at North Park University (NPU), has been named a 2025–26 Schweitzer Fellow, a prestigious honor given to graduate students to lead innovative, …
Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger - CrazyBulk
GlobeNewswire
·
July 28, 2025
New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025 In the evolving world of performance fitness, …
Regional Health Properties, Inc. Outlines Reasons for Regional Shareholders to Vote YES for Proposed Merger with SunLink Health Systems, Inc.
GlobeNewswire
·
July 28, 2025
ATLANTA, GA, July 28, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior …
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
GlobeNewswire
·
July 28, 2025
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company …
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
GlobeNewswire
·
July 28, 2025
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and …
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
GlobeNewswire
·
July 28, 2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen …
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
GlobeNewswire
·
July 28, 2025
Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company’s History International Cannabis Revenue Increased 71% in Q4 …
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire
·
July 28, 2025
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical …
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
GlobeNewswire
·
July 28, 2025
Informations Réglementées Châtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire biopharmaceutique …
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
GlobeNewswire
·
July 28, 2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with …
Assistive Technology Market Projected To Witness Massive Growth, 2025-2032 | Invacare Corporation,Ottobock SE & Co. KGaA
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The Assistive Technology Market is estimated to be valued at USD 25.34 Bn in 2025 and is expected to reach USD 35.66 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5% …
Abivax Announces Closing of $747.5 Million Public Offering
GlobeNewswire
·
July 28, 2025
Abivax Announces Closing of $747.5 Million Public Offering PARIS, France, July 28, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 28, 2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 in DMD fully enrolled to support …
Precision Medicine Market Projected To Witness Massive Growth, 2025-2032 | Pfizer Inc., Novartis AG, Intomics, GENinCode
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The precision medicine market is estimated to be valued at USD 102.93 Bn in 2025 and is expected to reach USD 220.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% …
U.S. 503B Compounding Pharmacies Market Projected To Witness Massive Growth 2025-2032 | QuVa Pharma, Olympia, ASP Cares
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The latest report (2025-2032) on the U.S. 503B Compounding Pharmacies Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the …
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
GlobeNewswire
·
July 28, 2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology …